StemCell Therapy

Nanorobots are electromechanical devices comprised of components that are within the nanometer size range. Within medicine, nanorobotic applications have been successfully used for a variety of microbiological, hematological, surgical and dental applications, to name a few.

The nanobots market global size accounted for USD 5.3 billion in 2021 and is expected to reach around USD 21.45 billion by 2030, expected to register growth at a CAGR of 16.8% from 2022 to 2030.

What is Biomedical Nanorobots?

As compared to industrial robots that were originally developed to automate routine and dangerous tasks, biomedical robots are highly specialized and miniature devices that must be capable of performing precise tasks within the human body. Recent advancements in nanotechnology and materials science have therefore promoted the development of both micro- and nanorobots for a wide range of biomedical applications.

Whereas the traditional power sources for industrial robots that require large power supplies and/or battery storage capabilities, both micro- and nanorobots will typically depend on chemically powered motors for their energy needs. To this end, these motors acquire energy by converting locally supplied fuels, such as oxygen or glucose within the body, to propel themselves towards different cellular structures. Nanorobots can also rely on externally powered motors based on either magnetic or ultrasound technology to drive their motion.

One of the most challenges that biomedical researchers have faced during the miniaturization of robotic systems has been the optimization of nanolocomotion. Recent developments in this field have demonstrated the ability of both micro- and nanorobots to efficiently propel themselves through complex biological media or narrow blood vessels. Furthermore, once these microscopic robots have penetrated through these areas, researchers have successfully developed ways in which these devices can collect and remove tissue biopsy samples, obtain detailed images, release active agents at predetermined locations and perform localized diagnoses.

Key market players

Report Scope of theNanobots Market

USD 21.45 Billion

Segments covered in the report

By Type

By Application

By Type of Manufacturing

By End User

Regional Segment

Nanomedicine segment is expected to dominate the application segment of the nanobots market

Based on application, the nanobots market is segmented into nanomedicine, biomedical and other applications. The Nanomedicine segment is expected to dominate the global nanobots market by holding more than 36% of the overall market. Nanobots are widely used in nanomedicine due to the increasing healthcare applications of nanobots. The large market share of this segment is attributed to the large level of commercialization in the healthcare sector for drug delivery, in vivo imaging, active implants, in vitro diagnostic, biomaterial, and drug therapy.

Additionally, increasing innovations in the field of cancer treatment related to the specific target are also contributing to the growth of nanobots market. The biomedical applications segment accounted for the second-largest market share of the overall nanobots marketplace.

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Download a FREE PDF Brochure https://www.precedenceresearch.com/sample/1914

Read more here:
Fundamental Knowledge on Nanobots - Bio-IT World

This entry was posted on July 25, 2022 at 2:03 am and is filed under Nano medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |